Pay in 4 interest-free payments of $5.13 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Allison Whitten AstraZeneca reports mixed Phase 3 results across oncology and rare disease AstraZeneca reported mixed late-stage clinical results, with its Claudin 18.2-targeting antibody-drug conjugate sonesitatug vedotin meeting its primary endpoint in patients with previously treated advanced gastric cancer, while rare disease therapy Ultomiris missed the primary endpoint in a Phase 3 trial for thrombotic microangiopathy following haematopoietic stem cell transplantation (HSCT-TMA)
Let's answer the burning question: do B12 injections require a prescription
Perfect B offers meaningful savings for patients who commit to two or three cycles upfront
The DEGs of G3 vs
Ipamorelin is generally used to produce a controlled secretagogue signal rather than constant receptor stimulation
CJC-1295, for example, is usually injected and can have effects that last for days, which if dosed incorrectly, poses the risk of sustaining hormone levels too long
US$ 22.74
US$ 20.33
US$ 20.50
